Medication info
Candesartan Cilexetil Tablet 16 mg

Candesartan Cilexetil Tablet 16 mg

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Light pinkish-yellow, round, biconvex tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202001795 · Approved 2020.03.16 · Insurance code 646005380

Summary

Main use
Treatment of essential hypertension and heart failure with left ventricular systolic dysfunction
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time each day, regardless of meals. Essential hypertension, adults: An initial and maintenance dose of 8 ∼ 16 mg of candesartan cilexetil is recommended orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment options should be considered. The maximum effect is reached within 4 weeks of starting treatment. Essential hypertension, elderly patients: No adjustment of the initial dose is necessary. Essential hypertension, patients with intravascular volume depletion: Administer an initial dose of 4 mg, exercising particular caution in patients at high risk of hypotension, such as those with volume depletion. Essential hypertension, patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. Essential hypertension, patients with hepatic impairment: The initial dose for patients with mild and moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. Heart failure, adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks and increased to a maximum of 32 mg once daily, depending on the patient's tolerability. Heart failure, elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
Essential hypertension, children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. Heart failure, children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with left ventricular systolic dysfunction

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • decreased left ventricular ejection fraction
View approved original text

This medication is used to treat essential hypertension and heart failure. It is particularly effective in heart failure patients with impaired left ventricular systolic function where monotherapy with an ACE inhibitor is insufficient or poorly tolerated. It helps improve cardiac function and alleviate symptoms in these patients. Therefore, it is used for the treatment of essential hypertension and specific heart failure patients.

How to take

Adult dose

This medicine should be taken at the same time each day, regardless of meals. Essential hypertension, adults: An initial and maintenance dose of 8 ∼ 16 mg of candesartan cilexetil is recommended orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment options should be considered. The maximum effect is reached within 4 weeks of starting treatment. Essential hypertension, elderly patients: No adjustment of the initial dose is necessary. Essential hypertension, patients with intravascular volume depletion: Administer an initial dose of 4 mg, exercising particular caution in patients at high risk of hypotension, such as those with volume depletion. Essential hypertension, patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. Essential hypertension, patients with hepatic impairment: The initial dose for patients with mild and moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. Heart failure, adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks and increased to a maximum of 32 mg once daily, depending on the patient's tolerability. Heart failure, elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

Essential hypertension, children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. Heart failure, children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn when used by pregnant women; therefore, it should be discontinued immediately upon confirmation of pregnancy. People with allergies to this drug or its components, pregnant or breastfeeding women, individuals with severe liver disease, and those with certain hereditary diseases should not use it. Elderly individuals, those with impaired kidney function, and patients with hyperkalemia should use this medication cautiously and have their blood pressure or kidney function monitored regularly. While taking this medication, side effects such as dizziness, headache, cough, and dyspepsia may occur. If there are unusual symptoms, it is advisable to consult a doctor. Particularly in heart failure patients, there is a risk of side effects including hypotension, worsening kidney function, and increased potassium levels, so careful monitoring and regular testing are necessary. If taken with other antihypertensives, diuretics, or potassium supplements, side effects may increase due to interactions, thus it is essential to inform the doctor. This medication should not be taken during pregnancy, and breastfeeding should either be avoided or breastfeeding should be discontinued while taking it. There is insufficient data on the safety and efficacy for children and adolescents under 18 years of age, so it is preferable not to use it in this population. In case of overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may occur, and immediate medical attention is required. This medication should be kept out of reach of children, and care should be taken not to transfer it to other containers.

Side effects

  • Dizziness
  • back pain
  • respiratory infections
  • upper respiratory tract infections
  • pharyngitis
  • rhinitis
  • weakness
  • fever
  • sensory disturbances
  • indigestion
Show 69 more
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • renal impairment
  • increased creatinine
  • increased urea
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • seizures
  • altered consciousness
  • increased liver enzyme levels
  • hepatitis
  • liver dysfunction
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • fainting
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbances
  • decreased libido
  • amnesia
  • appetite loss
  • increased appetite
  • tinnitus
  • taste disorders
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is best kept at room temperature between 1 to 30 degrees Celsius. Proper storage maintains the drug's efficacy and safety.

Appearance and packaging

Appearance

Light pinkish-yellow, round, biconvex tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.